Insights from 2023 ESMO Asia Annual Meeting
ESMO Asia 2023 Insights: "DeLLphi-301 Study - Tarlatamab for Patients With Previously Treated SCLC"
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Myung-Ju Ahn
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Myung-Ju Ahn
Comments 0
Login to view comments.
Click here to Login
